BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38566100)

  • 21. Pro-survival and anti-inflammatory roles of NF-κB c-Rel in the Parkinson's disease models.
    Wang Z; Dong H; Wang J; Huang Y; Zhang X; Tang Y; Li Q; Liu Z; Ma Y; Tong J; Huang L; Fei J; Yu M; Wang J; Huang F
    Redox Biol; 2020 Feb; 30():101427. PubMed ID: 31986466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral administration of sophoricoside (SOP) inhibits neuronal damage and neuroinflammation to curb neurodegeneration in Parkinson's disease.
    Wang H; He D; Li Z; Gao X; Yang S; Cui M; Ye B; Huang B; Fu S; Liu D
    Chem Biol Interact; 2023 Oct; 384():110726. PubMed ID: 37741537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bear bile powder alleviates Parkinson's disease-like behavior in mice by inhibiting astrocyte-mediated neuroinflammation.
    Wang L; Bai Y; Tao Y; Shen W; Zhou H; He Y; Wu H; Huang F; Shi H; Wu X
    Chin J Nat Med; 2023 Sep; 21(9):710-720. PubMed ID: 37777320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calycosin attenuates MPTP-induced Parkinson's disease by suppressing the activation of TLR/NF-κB and MAPK pathways.
    Yang J; Jia M; Zhang X; Wang P
    Phytother Res; 2019 Feb; 33(2):309-318. PubMed ID: 30421460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Amniotic Epithelial Cells Alleviate a Mouse Model of Parkinson's Disease Mainly by Neuroprotective, Anti-Oxidative and Anti-Inflammatory Factors.
    Zhang J; Li H; Yang H; Lin J; Wang Y; Zhang Q; Gao WQ; Xu H
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):620-633. PubMed ID: 33164162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early glycolytic reprogramming controls microglial inflammatory activation.
    Cheng J; Zhang R; Xu Z; Ke Y; Sun R; Yang H; Zhang X; Zhen X; Zheng LT
    J Neuroinflammation; 2021 Jun; 18(1):129. PubMed ID: 34107997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
    Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
    Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baohuoside I suppresses the NLRP3 inflammasome activation via targeting GPER to fight against Parkinson's disease.
    Gu Y; Hu ZF; Zheng DW; Yang YQ; Dong XL; Chen WF
    Phytomedicine; 2024 Apr; 126():155435. PubMed ID: 38394727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease.
    Ma C; Liu Y; Li S; Ma C; Huang J; Wen S; Yang S; Wang B
    CNS Neurosci Ther; 2023 Jul; 29(7):2018-2035. PubMed ID: 36914567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the TLR/NF-
    Su Y; Li M; Wang Q; Xu X; Qin P; Huang H; Zhang Y; Zhou Y; Yan J
    Oxid Med Cell Longev; 2022; 2022():1837278. PubMed ID: 36589679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
    Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
    Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of neuroinflammatory responses and behavioral deficits by Ligusticum officinale (Makino) Kitag in stimulated microglia and MPTP-induced mouse model of Parkinson's disease.
    Kim BW; Koppula S; Park SY; Kim YS; Park PJ; Lim JH; Kim IS; Choi DK
    J Ethnopharmacol; 2015 Apr; 164():388-97. PubMed ID: 25449453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RIPK1 Regulates Microglial Activation in Lipopolysaccharide-Induced Neuroinflammation and MPTP-Induced Parkinson's Disease Mouse Models.
    Kim DY; Leem YH; Park JS; Park JE; Park JM; Kang JL; Kim HS
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice.
    Lv Y; Zhang Z; Hou L; Zhang L; Zhang J; Wang Y; Liu C; Xu P; Liu L; Gai X; Lu T
    Neurosci Lett; 2015 Jun; 597():132-6. PubMed ID: 25929185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway.
    Jing H; Wang S; Wang M; Fu W; Zhang C; Xu D
    PLoS One; 2017; 12(1):e0169560. PubMed ID: 28060896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NADPH oxidase-derived H
    Hou L; Zhou X; Zhang C; Wang K; Liu X; Che Y; Sun F; Li H; Wang Q; Zhang D; Hong JS
    Redox Biol; 2017 Aug; 12():162-170. PubMed ID: 28237879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation.
    He Z; Hu Y; Zhang Y; Xie J; Niu Z; Yang G; Zhang J; Zhao Z; Wei S; Wu H; Hu W
    Phytomedicine; 2024 May; 127():155494. PubMed ID: 38471370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artemisinin exerts a protective effect in the MPTP mouse model of Parkinson's disease by inhibiting microglial activation via the TLR4/Myd88/NF-KB pathway.
    Lv J; Zhu J; Wang P; Liu T; Yuan J; Yin H; Lan Y; Sun Q; Zhang Z; Ding G; Zhou C; Wang H; Wang Z; Wang Y
    CNS Neurosci Ther; 2023 Apr; 29(4):1012-1023. PubMed ID: 36691817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.